VF Corp vs Zoetis Inc — how do they compare? VF Corp trades at $15 (market cap $5.71B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 5.3× VF Corp's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold VF Corp for 65 Days and Zoetis Inc for 70 Days on average.
| VFC | ZTS | |
|---|---|---|
Market Cap | $5.71B | $30.20B |
Volume | 8,987,330 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $21.55 | $147.53 |
52-Week Low | $12.62 | $69.09 |
Typical Hold Time | 65 Days | 70 Days |
Enterprise Value | $10.00B | $37.76B |
Dividend Yield | 2.48% | 2.9% |
Signals from Pluang's Aura AI — not financial advice
VFC trades at $14.53, up 1.04% with a bullish technical signal. The company shows mixed fundamentals with declining revenue from $11.8B in 2022 to $9.5B in 2025 and negative net income of -$189.72M, though 2026 projects a return to profitability. Analyst consensus is Hold with a $18.33 price target, representing 26% upside. Recent news highlights Vans brand weakness offset by Outdoor segment strength.
The outlook remains cautious with execution risk around the Vans turnaround being the key challenge. The discounted valuation (P/S 0.61) offers potential upside if management can stabilize operations, but persistent revenue declines and recent dividend cut signal ongoing headwinds. Risk-reward appears balanced near current levels.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.
ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.
Trailing returns across standard periods
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →